相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal
Catherine Larochelle et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal
Catherine Larochelle et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Disease activity return after natalizumab cessation in multiple sclerosis
Maria Rasenack et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Leber Hereditary Optic Neuropathy: Bringing the Lab to the Clinic
Nailyn Rasool et al.
SEMINARS IN OPHTHALMOLOGY (2016)
Disease activity return after natalizumab cessation in multiple sclerosis
Maria Rasenack et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy
Julian Borchardt et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis
Lucy Matthews et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Significant clinical worsening after natalizumab withdrawal: Predictive factors
A. Vidal-Jordana et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients
Per Soelberg Sorensen et al.
JOURNAL OF NEUROLOGY (2014)
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study)
Marinella Clerico et al.
JAMA NEUROLOGY (2014)
Pathology and disease mechanisms in different stages of multiple sclerosis
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations
Gerald Pfeffer et al.
NEUROLOGY (2013)
Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped
Theo Rispens et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Augusto Miravalle et al.
ARCHIVES OF NEUROLOGY (2011)
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
P. W. O'Connor et al.
NEUROLOGY (2011)
Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy
Jacqueline Palace
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
Aran F. Labrijn et al.
NATURE BIOTECHNOLOGY (2009)
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
B. O. Khatri et al.
NEUROLOGY (2009)
Neuropathology of white matter disease in Leber's hereditary optic neuropathy
GG Kovacs et al.
BRAIN (2005)
Leber's hereditary optic neuropathy presenting as multiple sclerosis-like disease of the CNS
R Horvath et al.
JOURNAL OF NEUROLOGY (2000)
分享论文
